5.55p
-0.89%
Close of 9 Nov 2026, in pence
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About OptiBiotix Health
Its shares trade on LSE under the ticker OPTI.L. It has been listed since 9 September 2011. In the fiscal year to 31 December 2025, it reported revenue of £1.2m and a net loss of £3.9m. At that date it held total assets of £6.9m and shareholders' equity of £6.3m.
Optibiotix Health Plc engages in the research and development of compounds which modify the human microbiome. The firm's principal activity is research and development into microbiome modulators. The company operates in UK segment. The firm has a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline is operated by its OptiScreen and OptiBiotic platform technologies designed to identify metabolic pathways and compounds that impact on human physiology. Its Optiscreen is a screening and optimization technology platform designed to identify microbes within the human microbiome with metabolic pathways, which can interact with human physiological processes. Its OptiBiotic is a platform technology, which generates compounds and screens them for their ability to modulate the human microbiome and its microbial end products. Its platforms are applicable across a range of other human diseases.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 9 Sept 2011
- Employees
- 10
- Website
- optibiotix.com ↗
Leadership
Pay as last reported
- Mr. Richard DavidsonNon-Executive Independent Chairman of the Board£66,000
- Mr. Stephen O'HaraChief Executive Officer, Executive Director, since 2015£286,000
- Mr. David BlainFinance Director, Executive Director, Company Secretary, since 2024
- Dr. Sofia KolydaExecutive Director - Research and Development Director, since 2018£75,000
- Mr. Michael ChristieNon-Executive Independent Director£29,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- OptiBiotix Health PLC has a strong pipeline of innovative and clinically proven products, giving it a competitive advantage in the health and wellness industry.
- The company has a strong intellectual property portfolio, providing it with a solid foundation for growth and protecting its products from potential competition.
- OptiBiotix Health PLC has an experienced management team with a deep understanding of the industry, enabling them to make informed strategic decisions.
Weaknesses
- As a relatively small company, OptiBiotix Health PLC may lack the financial resources and global reach of larger competitors, limiting its market penetration capabilities.
- The company may face challenges in scaling up production to meet increasing demand for its products, potentially leading to supply chain issues.
- OptiBiotix Health PLC's success heavily relies on the acceptance and adoption of its products by healthcare professionals and consumers, making it vulnerable to changing market preferences.
Opportunities
- The growing consumer interest in natural and preventative health solutions presents a significant opportunity for OptiBiotix Health PLC to expand its customer base and increase sales.
- As the importance of gut health gains more recognition worldwide, OptiBiotix Health PLC can capitalize on the rising demand for probiotics and other gut microbiome-based products.
- The company has the potential to forge strategic partnerships with established players in the industry, leveraging their distribution networks and enhancing market access.
Threats
- OptiBiotix Health PLC operates in a highly competitive market, facing competition from both established companies and new market entrants with similar product offerings.
- Regulatory challenges and changes in government policies related to health and wellness products can pose significant threats to OptiBiotix Health PLC's operations and marketability.
- Emerging scientific research and development in the field of microbiome-based therapies may result in the discovery of new products that could outperform or replace OptiBiotix Health PLC's existing offerings.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.